[ALNY] YoY Quarter Result on 30-Jun-2009 [#Q2]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
06-Aug-2009
Financial Year
2009
Quarter
30-Jun-2009 [#Q2]
Profit Trend
QoQ- -187.77%
YoY- -77.92%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Revenue 20,884 20,614 26,617 24,601 23,833 9,133 6,021 23.01%
PBT -12,956 -13,824 -14,861 -21,794 -11,509 -12,691 -9,910 4.56%
Tax -2,855 -1,593 -229 908 1,251 -2,262 -1,199 15.54%
NP -12,956 -13,824 -14,632 -22,702 -12,760 -12,691 -9,910 4.56%
Tax Rate - - - - - - - -
Total Cost 33,840 34,438 41,249 47,303 36,593 21,824 15,931 13.36%
Ratio Analysis
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
NP Margin -62.04 -67.06 -54.97 -92.28 -53.54 -138.96 -164.59 -14.99%
Per Share
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
EPS -0.25 -0.33 -0.35 -0.55 -0.31 -0.34 -0.31 -3.51%
EPS Diluted -0.25 -0.33 -0.35 -0.55 -0.31 -0.34 -0.31 -3.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.